Orgenesis (ORGS) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free ORGS Stock Alerts $0.50 +0.04 (+8.70%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrends Orgenesis Short Interest DataCurrent Short Interest249,300 sharesPrevious Short Interest288,100 sharesChange Vs. Previous Month-13.47%Dollar Volume Sold Short$141,029.01Short Interest Ratio1.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares34,450,000 sharesPercentage of Shares Shorted0.72%Today's Trading Volume17,081 sharesAverage Trading Volume176,032 sharesToday's Volume Vs. Average10% Short Selling Orgenesis ? Sign up to receive the latest short interest report for Orgenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORGS Short Interest Over TimeORGS Days to Cover Over TimeORGS Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Orgenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024249,300 shares $141,029.01 -13.5%N/A1.4 $0.57 4/30/2024288,100 shares $145,605.74 -28.4%N/A1.3 $0.51 4/15/2024402,500 shares $201,129.25 +34.3%N/A1.7 $0.50 3/31/2024299,700 shares $246,353.40 -7.0%N/A1.9 $0.82 3/15/2024322,200 shares $254,280.24 +42.8%N/A2.2 $0.79 2/29/2024225,700 shares $144,493.14 -7.4%N/A1.5 $0.64 Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024243,800 shares $117,024.00 +61.6%N/A1.7 $0.48 1/31/2024150,900 shares $47,382.60 +25.2%N/A1.6 $0.31 1/15/2024120,500 shares $36,029.50 -36.4%N/A1.3 $0.30 12/31/2023189,500 shares $94,882.65 +47.0%N/A2.4 $0.50 12/15/2023128,900 shares $63,844.17 -39.3%N/A1.8 $0.50 11/30/2023212,300 shares $97,997.68 -12.2%N/A3.4 $0.46 11/15/2023241,900 shares $133,045.00 +21.5%N/A2.4 $0.55 10/31/2023199,100 shares $135,407.91 -18.7%0.8%1.8 $0.68 10/15/2023244,800 shares $206,537.76 +18.4%1.0%2.5 $0.84 9/30/2023206,800 shares $128,216.00 -29.0%0.9%2.1 $0.62 9/15/2023291,400 shares $201,066.00 +45.4%1.2%3.1 $0.69 8/31/2023200,400 shares $102,023.64 +2.4%0.9%2.3 $0.51 8/15/2023195,700 shares $192,568.80 +8.6%N/A4.4 $0.98 7/31/2023180,200 shares $196,418.00 -13.3%N/A6.5 $1.09 7/15/2023207,900 shares $270,270.00 -7.2%N/A7.1 $1.30 6/30/2023224,100 shares $311,499.00 +13.6%N/A7.4 $1.39 6/15/2023197,200 shares $256,360.00 -1.0%N/A5.5 $1.30 5/31/2023199,100 shares $236,929.00 +6.9%N/A4.4 $1.19 5/15/2023186,300 shares $199,359.63 -11.5%N/A2.4 $1.07 4/30/2023210,600 shares $231,660.00 -43.4%N/A2.8 $1.10 4/15/2023372,100 shares $427,915.00 -17.2%N/A5 $1.15 3/31/2023449,600 shares $530,528.00 +47.5%N/A5.9 $1.18 3/15/2023304,800 shares $377,952.00 -19.1%1.3%4.3 $1.24 2/28/2023376,800 shares $542,592.00 +91.0%1.6%6.3 $1.44 2/15/2023197,300 shares $420,249.00 +0.4%1.0%3.4 $2.13 1/31/2023196,600 shares $471,840.00 -12.7%1.0%1.8 $2.40 1/15/2023225,100 shares $535,738.00 +2.4%1.1%2 $2.38 12/30/2022219,800 shares $428,610.00 +4.9%1.0%2 $1.95 12/15/2022209,500 shares $427,380.00 -5.1%1.0%1.9 $2.04 11/30/2022220,800 shares $441,600.00 -25.9%1.0%2.1 $2.00 11/15/2022298,000 shares $643,680.00 +53.8%1.4%2.9 $2.16 10/31/2022193,800 shares $259,692.00 +2.1%0.9%1.8 $1.34 10/15/2022189,900 shares $241,173.00 -4.7%0.8%5.1 $1.27 9/30/2022199,300 shares $283,006.00 +28.5%0.9%5.8 $1.42Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! 9/15/2022155,100 shares $285,384.00 -9.9%0.7%4.8 $1.84 8/31/2022172,200 shares $334,068.00 +13.1%0.8%5.1 $1.94 8/15/2022152,300 shares $284,801.00 -10.4%0.7%4.2 $1.87 7/31/2022169,900 shares $316,014.00 -17.0%0.8%4 $1.86 7/15/2022204,600 shares $460,350.00 -8.7%0.9%5.6 $2.25 6/30/2022224,100 shares $542,322.00 +37.7%1.0%6.2 $2.42 6/15/2022162,700 shares $323,773.00 -24.5%0.7%3.4 $1.99 5/31/2022215,400 shares $553,578.00 +52.4%1.0%4.8 $2.57 5/15/2022141,300 shares $402,705.00 -3.2%0.6%3.2 $2.85 4/30/2022145,900 shares $437,700.00 -27.6%0.7%4.8 $3.00 4/15/2022201,500 shares $687,115.00 +6.1%0.9%5.4 $3.41 3/31/2022190,000 shares $659,300.00 +2.9%0.9%4 $3.47 3/15/2022184,700 shares $528,242.00 -19.3%0.9%3.6 $2.86 2/28/2022229,000 shares $721,350.00 -11.9%1.1%3.7 $3.15 2/15/2022259,900 shares $813,487.00 +4.9%1.3%3.7 $3.13 1/31/2022247,700 shares $775,301.00 +12.8%1.2%3 $3.13 1/15/2022219,600 shares $507,276.00 -6.7%1.0%2.5 $2.31 12/31/2021235,400 shares $677,952.00 +0.3%1.1%2.8 $2.88 12/15/2021234,600 shares $694,416.00 +9.4%1.1%3.4 $2.96 11/30/2021214,500 shares $664,950.00 -14.8%1.0%3.4 $3.10 11/15/2021251,700 shares $1.02 million -1.1%1.2%4.4 $4.06 10/29/2021254,400 shares $1.22 million -17.3%1.2%4.7 $4.81 10/15/2021307,500 shares $1.46 million -25.7%1.4%6.3 $4.76 9/30/2021413,600 shares $2.05 million -27.9%1.9%8 $4.95 9/15/2021573,800 shares $2.85 million -3.7%2.7%5.9 $4.96 8/31/2021595,900 shares $3.19 million +3.0%2.8%5.1 $5.35 8/13/2021578,500 shares $2.99 million -20.5%2.7%4.2 $5.16 7/30/2021727,700 shares $3.57 million +8.9%3.4%4 $4.90 7/15/2021668,300 shares $3.21 million -2.2%3.1%1.4 $4.80 6/30/2021683,000 shares $3.46 million -62.7%3.2%1.5 $5.07 6/15/20211,830,000 shares $9.50 million No Change8.5%4.1 $5.19 5/28/20211,830,000 shares $8.84 million +16.6%8.5%4.1 $4.83 5/14/20211,570,000 shares $6.92 million +36.5%N/A3.5 $4.41 4/30/20211,150,000 shares $5.42 million +31.0%N/A2.6 $4.71 4/15/2021878,000 shares $4.64 million +16.6%N/A6 $5.28 3/31/2021753,000 shares $4.18 million +37.8%N/A4.1 $5.55 3/15/2021546,600 shares $4.42 million +62.6%N/A3.1 $8.08 2/26/2021336,100 shares $2.32 million +6.9%N/A2.2 $6.89 2/12/2021314,500 shares $2.09 million -3.5%N/A2.4 $6.66 1/29/2021326,000 shares $2.04 million -2.1%N/A2.9 $6.25 1/15/2021332,900 shares $1.70 million -2.7%N/A3.3 $5.12 12/31/2020342,200 shares $1.56 million +2.9%N/A6.6 $4.55 12/15/2020332,600 shares $1.57 million -13.4%N/A7.2 $4.72 11/30/2020384,100 shares $1.90 million +0.6%N/A8.8 $4.95 11/15/2020382,000 shares $1.86 million -0.2%N/A8.9 $4.86 10/30/2020382,700 shares $1.78 million -8.9%N/A8.9 $4.66 10/15/2020420,200 shares $2.21 million -0.9%N/A8.8 $5.26 ORGS Short Interest - Frequently Asked Questions What is Orgenesis' current short interest? Short interest is the volume of Orgenesis shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 249,300 shares of ORGS short. Learn More on Orgenesis' current short interest. What is a good short interest ratio for Orgenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGS shares currently have a short interest ratio of 1.0. Learn More on Orgenesis's short interest ratio. Is Orgenesis' short interest increasing or decreasing? Orgenesis saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 249,300 shares, a decline of 13.5% from the previous total of 288,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Orgenesis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Orgenesis: Immix Biopharma, Inc. (2.38%), Theratechnologies Inc. (0.11%), CalciMedica, Inc. (0.59%), Leap Therapeutics, Inc. (5.29%), Reneo Pharmaceuticals, Inc. (16.73%), BioLineRx Ltd. (0.27%), Carisma Therapeutics, Inc. (7.78%), Rockwell Medical, Inc. (2.11%), Anebulo Pharmaceuticals, Inc. (0.07%), Tharimmune, Inc. (0.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Orgenesis stock? Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. ORGS shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orgenesis? A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further. How often is Orgenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Immix Biopharma Short Interest Theratechnologies Short Interest CalciMedica Short Interest Leap Therapeutics Short Interest Reneo Pharmaceuticals Short Interest BioLineRx Short Interest Carisma Therapeutics Short Interest Rockwell Medical Short Interest Anebulo Pharmaceuticals Short Interest Tharimmune Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGS) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWrite this ticker symbol down…StocksToTradeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWho are Nvidia’s New Silent Partners?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.